DNTT
Basic information
Region (hg38): 10:96304409-96338564
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNTT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 26 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 26 | 4 | 4 |
Variants in DNTT
This is a list of pathogenic ClinVar variants found in the DNTT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-96304532-G-A | not specified | Uncertain significance (Jul 11, 2023) | ||
10-96304639-C-A | not specified | Uncertain significance (Dec 27, 2023) | ||
10-96304683-G-T | not specified | Uncertain significance (Nov 14, 2023) | ||
10-96304707-C-G | Benign (Aug 09, 2018) | |||
10-96304709-G-A | Benign (Feb 13, 2018) | |||
10-96318387-C-T | not specified | Uncertain significance (Jan 31, 2024) | ||
10-96318414-A-C | not specified | Uncertain significance (Apr 01, 2024) | ||
10-96318417-C-T | Benign (Dec 31, 2019) | |||
10-96318475-A-T | not specified | Uncertain significance (Aug 16, 2021) | ||
10-96319270-A-G | Likely benign (Jul 31, 2018) | |||
10-96319293-C-T | not specified | Uncertain significance (Dec 16, 2022) | ||
10-96319302-C-G | not specified | Uncertain significance (Nov 18, 2022) | ||
10-96319330-G-T | not specified | Uncertain significance (May 25, 2022) | ||
10-96319378-C-T | Benign (Dec 31, 2019) | |||
10-96320673-G-A | not specified | Likely benign (Jan 16, 2024) | ||
10-96320691-C-T | not specified | Uncertain significance (Oct 16, 2024) | ||
10-96320741-A-T | not specified | Uncertain significance (Dec 13, 2022) | ||
10-96322696-G-T | not specified | Uncertain significance (Sep 26, 2023) | ||
10-96322710-A-G | Benign (Mar 28, 2018) | |||
10-96324272-A-T | not specified | Uncertain significance (Oct 30, 2023) | ||
10-96324353-G-C | Likely benign (Aug 10, 2018) | |||
10-96327477-A-G | not specified | Uncertain significance (Jun 18, 2021) | ||
10-96327514-A-C | not specified | Uncertain significance (Oct 20, 2023) | ||
10-96327524-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
10-96327597-G-A | not specified | Uncertain significance (Nov 15, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNTT | protein_coding | protein_coding | ENST00000371174 | 11 | 34237 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.95e-10 | 0.725 | 125654 | 1 | 90 | 125745 | 0.000362 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.466 | 314 | 292 | 1.08 | 0.0000165 | 3347 |
Missense in Polyphen | 122 | 112.8 | 1.0816 | 1291 | ||
Synonymous | -0.0165 | 107 | 107 | 1.00 | 0.00000614 | 943 |
Loss of Function | 1.50 | 19 | 27.5 | 0.690 | 0.00000146 | 327 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000731 | 0.000731 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000478 | 0.000475 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000330 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Template-independent DNA polymerase which catalyzes the random addition of deoxynucleoside 5'-triphosphate to the 3'-end of a DNA initiator. One of the in vivo functions of this enzyme is the addition of nucleotides at the junction (N region) of rearranged Ig heavy chain and T-cell receptor gene segments during the maturation of B- and T-cells. {ECO:0000250|UniProtKB:P09838}.;
- Pathway
- Hematopoietic cell lineage - Homo sapiens (human);Non-homologous end-joining - Homo sapiens (human);Validated targets of C-MYC transcriptional repression;DNA-PK pathway in nonhomologous end joining
(Consensus)
Recessive Scores
- pRec
- 0.926
Intolerance Scores
- loftool
- 0.900
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 33.42
Haploinsufficiency Scores
- pHI
- 0.133
- hipred
- Y
- hipred_score
- 0.755
- ghis
- 0.398
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.837
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dntt
- Phenotype
- homeostasis/metabolism phenotype; normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- DNA metabolic process;double-strand break repair via nonhomologous end joining;DNA modification;response to ATP;DNA biosynthetic process
- Cellular component
- nuclear chromatin;euchromatin;nucleus;nucleoplasm;cytosol;nuclear matrix
- Molecular function
- DNA binding;DNA-directed DNA polymerase activity;DNA nucleotidylexotransferase activity;protein binding;metal ion binding